Previous studies showed that tempol, an antioxidant, and antibiotic treatments resulted in reduction of the genus Lactobacillus, thus improving obesity, NAFLD, and insulin resistance via inhibition of intestinal FXR signaling (9, 11). Here, NR1H4 is linked to obesity due to melanocortin 4 receptor deficiency.